Navigation Links
PRC Clinical Announces Completion of First Patient Cohort in UC Davis Regenerative Medicine Study in Musculoskeletal Diseases
Date:8/30/2017

PRC Clinical, an expert Clinical Trial Management CRO, today announced the completion of the first patient cohort in a clinical study with the University of California, Davis, School of Medicine.

The program is studying a directed regenerative approach to musculoskeletal and aging related disease. The study is headed by Nancy E. Lane, MD at the University of California, Davis, School of Medicine and is funded by a grant from the California Institute of Regenerative Medicine. Lane is an endowed professor of Medicine, Rheumatology, and Aging Research at UC Davis, and director of the UC Davis Center for Musculoskeletal Health.

Additionally, PRC Clinical is also supporting University of California, San Francisco (UCSF) since 2014 with clinical trial management services for a four-year Phase I, Parkinson’s disease clinical study. The study is evaluating safety for a vector based, gene-therapy treatment developed at UCSF. “We are thrilled to bring personalized CRO services to the academic world,” said Curtis Head, CEO of PRC Clinical, “and to renew our commitment to advancing innovative regenerative medicine treatments.”

PRC Clinical will be present at the Stem Cell Meeting on the Mesa October 4-6, 2017 in La Jolla, CA. The Stem Cell Meeting on the Mesa is a three-day conference on regenerative medicine and advanced therapies gathering the scientific community to advance cutting-edge research into treatments and cures.

About PRC Clinical

PRC Clinical is the CRO of choice for many pharmaceutical, biotech and regenerative medicine developers worldwide, offering a next-level clinical trial management experience. Our innovative approach to executing studies merges our high-touch human element with high-tech tools, extensive experience and deep knowledge – far exceeding the level of service offered by large CROs. We offer full Clinical Trial Management services including Clinical Project Management, Site Monitoring, Quality Assurance, Drug Safety, Payment Services, Biostatistics, Data Management, Regulatory Strategies, and Site Selection and Enrollment. PRC clinical has significant experience in a wide range of therapeutic areas: Regenerative Medicine, CNS, Neurology, ALS, Parkinson’s, Pain, GI, Device, Anti-infective, Cardiovascular, Pulmonary, Oncology, and Stem cells. Visit http://www.prcclinical.com, call 1-877-519-6001, or email info(at)prcclinical(dot)com.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14644652.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
3. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
4. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
5. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
6. Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
7. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
8. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
9. Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
10. ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
11. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... ... 2017 , ... Proscia Inc ., a data solutions ... “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, Managing ... how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... as part of its corporate rebranding initiative announced today. The bold new look ... its reach, as the company moves into a significant growth period. , It will ...
Breaking Biology Technology:
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/13/2017)... MONICA, Calif. , April 13, 2017 ... New York will feature emerging and evolving ... Summits. Both Innovation Summits will run alongside the expo ... of speaker sessions, panels and demonstrations focused on trending ... coast,s largest advanced design and manufacturing event will take ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Biology News(10 mins):